The European Commission announced on Saturday that all new electronic devices sold in the European Union (E.U.) must support ...

Nkarta focuses on autoimmune diseases, with $402.5M in cash. Read why NKTX stock, currently undervalued, offers multiple ...

Human induced pluripotent stem cells (hiPSCs) are considered a promising tool in medicine, with the potential to unlock ...

The reinsurance market is in a strong financial position at the 1/1 renewal, according to the reinsurance broker's "1st View ...

In a groundbreaking development, researchers at KAIST (Korea Advanced Institute of Science and Technology) unveiled a new ...

Im Jeong-bae, the chief executive officer of Daesang, noted that this year, the company should achieve qualitative growth ...

Apple’s smartwatch has become synonymous with innovation and quality. With its extensive features and seamless integration ...

This article highlights how to differentiate between heart pain and gas pain, emphasizing the importance of recognizing heart ...

What’s the outlook—and opportunity—for CX in 2025? It looks like 2025 will be another year of CX mediocrity for most brands. Don’t lose hope! For the bold CX leaders who are ready to kick things into ...

The most-read stories published by Multiple Sclerosis News Today in 2024 focused on living with MS and news on disease risk ...

Researchers hunting for a cure for cancer have made a groundbreaking discovery that could turn some cancer cells into 'normal ...

This is a significant departure from traditional cancer treatments that rely on killing cancer cells, often leading to severe ...